ATE201233T1 - Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon - Google Patents

Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon

Info

Publication number
ATE201233T1
ATE201233T1 AT99923698T AT99923698T ATE201233T1 AT E201233 T1 ATE201233 T1 AT E201233T1 AT 99923698 T AT99923698 T AT 99923698T AT 99923698 T AT99923698 T AT 99923698T AT E201233 T1 ATE201233 T1 AT E201233T1
Authority
AT
Austria
Prior art keywords
peptide
tgf
nucleic acid
acid sequence
peptide encoded
Prior art date
Application number
AT99923698T
Other languages
English (en)
Inventor
Bruce Acres
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE201233T1 publication Critical patent/ATE201233T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99923698T 1998-06-08 1999-06-08 Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon ATE201233T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9807322A FR2779432A1 (fr) 1998-06-08 1998-06-08 Sequence nucleique du recepteur rii du tgfb, peptide code, et utilisations
PCT/FR1999/001354 WO1999064588A1 (fr) 1998-06-08 1999-06-08 SEQUENCE NUCLEIQUE DU RECEPTEUR RII DU TGFβ, PEPTIDE CODE, ET UTILISATIONS

Publications (1)

Publication Number Publication Date
ATE201233T1 true ATE201233T1 (de) 2001-06-15

Family

ID=9527246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99923698T ATE201233T1 (de) 1998-06-08 1999-06-08 Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon

Country Status (12)

Country Link
EP (1) EP0994948B1 (de)
JP (1) JP2002517240A (de)
AT (1) ATE201233T1 (de)
AU (1) AU741558B2 (de)
CA (1) CA2299678A1 (de)
DE (1) DE69900109T2 (de)
DK (1) DK0994948T3 (de)
ES (1) ES2158734T3 (de)
FR (1) FR2779432A1 (de)
GR (1) GR3036288T3 (de)
PT (1) PT994948E (de)
WO (1) WO1999064588A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170106066A1 (en) * 2014-06-10 2017-04-20 Universitetet I Oslo Engineered invariant chain molecule for improved mhc class i loading
GB201608052D0 (en) * 2016-05-09 2016-06-22 Univ Oslo Hf T-cell receptors which recognise frameshift mutants of TGF-beta RII

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866323A (en) * 1995-04-07 1999-02-02 Case Western Reserve University Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors

Also Published As

Publication number Publication date
WO1999064588A1 (fr) 1999-12-16
DK0994948T3 (da) 2001-08-27
FR2779432A1 (fr) 1999-12-03
DE69900109T2 (de) 2002-01-03
AU741558B2 (en) 2001-12-06
ES2158734T3 (es) 2001-09-01
GR3036288T3 (en) 2001-10-31
DE69900109D1 (de) 2001-06-21
AU4047199A (en) 1999-12-30
EP0994948A1 (de) 2000-04-26
PT994948E (pt) 2001-11-30
EP0994948B1 (de) 2001-05-16
JP2002517240A (ja) 2002-06-18
CA2299678A1 (fr) 1999-12-16

Similar Documents

Publication Publication Date Title
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
ATE368053T1 (de) Antimikrobielle peptide
CA2289914A1 (en) Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof
NZ505880A (en) IL-18 receptor polypeptides
ATE529434T1 (de) Transfektionskomplexe
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
AU5776799A (en) Modified hcv peptide vaccines
ATE201233T1 (de) Tgf-beta rii rezeptor nukleinsäuresequenz, dadurch kodiertes peptid, und verwendungen davon
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
GB9416536D0 (en) Orphan receptor
DE60109412D1 (en) Therapeutische peptide
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
WO2002038607A3 (en) A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
EP1013665A4 (de) Neue polypeptide mit wasserkanalaktivität und dna sequenzen
IL142664A0 (en) Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same
WO2002092624A3 (en) G-protein coupled receptor
DE60021707D1 (de) Beta-primeverosidase gen
TR199701538T1 (xx) Helibakter pilor'un n�kleik asit ve amino asit sekanslar�.
DK1158050T3 (da) Human cysteinyl-leukotrienreceptor (CysLT2)
WO2002048360A1 (fr) Genes du recepteur des oestrogenes et leur utilisation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee